Tumor-infiltrating lymphocytes: A new hope.
Cancer Cell
; 42(8): 1315-1318, 2024 Aug 12.
Article
in En
| MEDLINE
| ID: mdl-39029463
ABSTRACT
Tumor-infiltrating lymphocytes (TILs) can be massively expanded from resected tumors and used as a cellular treatment for advanced malignancies. TILs require a preparative non-myeloablative chemotherapy followed by an abbreviated course of interleukin-2. Here, we review the historical development of TIL therapy and discuss potential solutions to ongoing roadblocks that may result in broader and improved efficacy for patients afflicted with treatment-refractory, advanced cancer.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphocytes, Tumor-Infiltrating
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Cancer Cell
/
Cancer cell
Journal subject:
NEOPLASIAS
Year:
2024
Document type:
Article
Country of publication:
Estados Unidos